Relevant bibliographies by topics / Lurasidone Hcl

Contents

  1. Journal articles
  2. Book chapters

Academic literature on the topic 'Lurasidone Hcl'

Author: Grafiati
Published: 4 June 2025
Last updated: 14 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lurasidone Hcl.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lurasidone Hcl"

1

El-Beshlawy, Menna M., Ahmed Barhoum, and Fatehy M. Abdel-Haleem. "Nanomolar detection of lurasidone hydrochloride in pharmaceutical formulations (Serodopamoun®) and spiked urine using a PVC/imprinted polymer/MWCNTs layer deposited onto polyaniline-coated screen-printed electrodes." RSC Advances 14, no. 53 (2024): 39769–78. https://doi.org/10.1039/d4ra07098d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mittal, Ankit, Manish Yadav, Dinesh Choudhary, and Birendra Shrivastava. "ENHANCEMENT OF SOLUBILITY OF LURASIDONE HCL USING SOLID DISPERSION TECHNIQUE." International Journal of Research in Ayurveda & Pharmacy 5, no. 5 (2014): 632–37. http://dx.doi.org/10.7897/2277-4343.055129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Simranjeet, Singh Muskan Sood Anu Jindal* Rajmeet Singh Satvinder Kaur Jaswinder Singh Shaveta Bhardwaj. "Analytical Method Validation of Tablet Dosage Form of Lurasidone HCl." International Journal in Pharmaceutical Sciences 1, no. 11 (2023): 240–45. https://doi.org/10.5281/zenodo.10112998.

Full text
Abstract:
This research is mainly focused on development of an Excellent Gradient method by reverse phase - high performance liquid chromatography (RP-HPLC) using UV Visible Detector. The main objective of method validation of Lurasidone HCl as a tablet dosage form is to validate the method as in-house method. As this tablet dosage form is not registered in any of Pharmacopeia, so the method is developed and validated for further studies. The sample is analyzed by RP-HPLC using octadecylsilane (C18) column (Inertsil LC-GC) as stationary phase with UV-Visible detector. The 'Gradient Method' is used as in
APA, Harvard, Vancouver, ISO, and other styles
4

Simranjeet, Singh Muskan Sood Anu Jindal* Rajmeet Singh Satvinder Kaur Jaswinder Singh Shaveta Bhardwaj. "Analytical Method Validation of Tablet Dosage Form of Lurasidone HCl." International Journal in Pharmaceutical Sciences 1, no. 11 (2023): 240–45. https://doi.org/10.5281/zenodo.10113218.

Full text
Abstract:
This research is mainly focused on development of an Excellent Gradient method by reverse phase - high performance liquid chromatography (RP-HPLC) using UV Visible Detector. The main objective of method validation of Lurasidone HCl as a tablet dosage form is to validate the method as in-house method. As this tablet dosage form is not registered in any of Pharmacopeia, so the method is developed and validated for further studies. The sample is analyzed by RP-HPLC using octadecylsilane (C18) column (Inertsil LC-GC) as stationary phase with UV-Visible detector. The 'Gradient Method
APA, Harvard, Vancouver, ISO, and other styles
5

Vijaya Sri, K., M. Shiva Kumar, and A. Sravani. "RAPID RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF LURASIDONE HYHROCHLORIDE IN BULK AND TABLET FORM." INDIAN DRUGS 54, no. 01 (2017): 28–34. http://dx.doi.org/10.53879/id.54.01.10572.

Full text
Abstract:
The RP-HPLC were developed and validated for the estimation of lurasidone HCl as per ICH guidelines. A simple, fast, accurate and precise RP-HPLC method was developed by using methanol: water containing 0.01% ortho phosphoric acid in the ratio of 70:30 (V/V). The method was developed in Eclipse C18 column (100 mm × 4.6 mm, 3.5 μm particle size). The method was found to be linear in the range of 2.5- 15µg/mL with a correlation coefficient value of 0.999. The accuracy studies of RP-HPLC method was performed at three different levels, i.e., 50%, 100%, and 150% and recovery was found to be in the
APA, Harvard, Vancouver, ISO, and other styles
6

Suneetha, A., K. Manasa, and S. Lakshmi Sindhura. "Stability Indicating RP-HPLC Method for Determination and Validation of Lurasidone HCL in Bulk and Pharmaceutical Dosage Forms." Journal of Pharmaceutical Research 14, no. 1 (2015): 15. http://dx.doi.org/10.18579/jpcrkc/2015/14/1/78370.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Patel, Mrunali R., Rashmin B. Patel, Shivam D. Thakore, and Ajay B. Solanki. "Brain targeted delivery of lurasidone HCl via nasal administration of mucoadhesive nanoemulsion formulation for the potential management of schizophrenia." Pharmaceutical Development and Technology 25, no. 8 (2020): 1018–30. http://dx.doi.org/10.1080/10837450.2020.1772292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ramanjaneyulu, Siddabathuni, K. M. V. Narayana Rao, and Shyamala Pulipaka. "Assessment of Novel Stability-Indicating Technique-based HPLC Approach for One Genotoxic Impurity and Three Related Substance Impurities of Lurasidone Hydrochloride: Degradation Studies on Lurasidone Hydrochloride." Asian Journal of Chemistry 34, no. 7 (2022): 1825–34. http://dx.doi.org/10.14233/ajchem.2022.23783.

Full text
Abstract:
The present work communicates the selective quantification of a genotoxic impurity (P-LUH) and lurasidone hydrochloride (LUH) related compounds (I1-LUH, I2-LUH and I3-LUH) as potential impurities in the LUH active therapeutic ingredient using novel stability-indicating technique-based HPLC approach. The P-LUH, I1-LUH, I2-LUH and I3-LUH were separated on column Inerstil ODS 3V having length size of 250 mm, identification value of 4.6 mm and particle dimension of 5 μm. After that, a high sensitivity PDA detector at 231 nm was used to detect the signal of impurities. The method was thoroughly val
APA, Harvard, Vancouver, ISO, and other styles
9

Patel, Mitali H., Veenu P. Mundada, and Krutika K. Sawant. "Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia." Drug Development and Industrial Pharmacy 45, no. 8 (2019): 1242–57. http://dx.doi.org/10.1080/03639045.2019.1593434.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

ARIRAHMAYANTI, I. GUSTI AYU EKA, I. GUSTI AYU INDAH ARDANI, and MUHAMAD SUHARDI. "GANGGUAN SKIZOAFEKTIF DENGAN KOMORBIDITAS DIABETES MELITUS : SEBUAH TINJAUAN PUSTAKA." KNOWLEDGE: Jurnal Inovasi Hasil Penelitian dan Pengembangan 4, no. 3 (2024): 96–106. https://doi.org/10.51878/knowledge.v4i3.3679.

Full text
Abstract:
The prevalence rate is that individuals with schizophrenia and schizoaffective disorder have more than twice the risk of developing type 2 diabetes mellitus (T2DM) compared to the general population. People on the schizophrenia spectrum are genetically predisposed to type II diabetes, accompanied by weight gain as a side effect of treatment, which is a risk factor for developing type 2 diabetes, which will worsen medical outcomes and mortality rates. This literature review involves 21 journal and book literature from the last 10 years regarding schizoaffective with comorbid diabetes mellitus.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Lurasidone Hcl"

1

Jain, Paras, N. V. D. Prasad Ketha, and Buchi N. Nalluri. "A High-Performance Liquid Chromatographic Method for Dissolution Testing of Lurasidone Tablets." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00296.

Full text
Abstract:
A simple, rapid, selective, and reproducible HPLC method for Lurasidone Hydrochloride tablet release estimation has been developed and validated. An Agilent, X-Bridge column C18,150*4.6 mm, 3.5m was used to produce a symmetrical peak form at a regulated column temperature of 25°C with a flow rate of 1.5 mL/min, a mobile phase component of A and B in the ratio of 30:70, a run time of 14 minutes, and an isocratic elution. Mobile phase A is 0.2% ammonia in water with a pH of 8.5, and mobile phase B is 98:2 acetonitrile and water. At 232 nm, 25 μL sample solutions were injected. A two-stage acid-buffer dissolution condition simulated GI transit pH shift was used. The acid stage consisted of 500 mL of 0.1N HCl solution in each vessel USP apparatus-2 at 75 rpm for 60 minutes, followed by 500 mL of concentrated buffer media in each vessel and continued dissolution with the same parameters. Dissolution method suitability, specificity, precision, accuracy, linearity, robustness, and solution stability have been verified. From the validation data, a set of system appropriateness requirements for the approach have been created. The minimum level at which the technique was found to be sensitive to LH was1.2 µg/mL, 1.2 µg/mL to 18.0 µg/mL was the range for the method’s development, which was based on accuracy and linearity tests. The solutions passed a 24-hour stability test while being stored at room temperature.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Lurasidone Hcl' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography